Otros idiomas PolyPid Ltd.

Acciones

PYPD

IL0011326795

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
4,752 ^USD	-1,12 %		+8,01 %	+25,07 %

14/02	Transcript : PolyPid Ltd., Q4 2023 Earnings Call, Feb 14, 2024
14/02	PolyPid Ltd. Resultados del cuarto trimestre y del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024	24/04
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference	28/02
PolyPid Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	14/02
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial	12/02
PolyPid Ltd. Announces Enrollment of the 100th Patient in the Ongoing Shield II Phase 3 Trial	12/02
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024	31/01
PolyPid Ltd. announced that it has received $35.01012 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc.	22/01
PolyPid Enters Into $16.2 Million Private Placement Deal	05/01
PolyPid Announces Private Placement for $16 Million in Gross Proceeds	04/01
PolyPid Ltd. announced that it expects to receive $16.216011 million in funding from Dafna Capital Management, LLC, Rosalind Advisors, Inc. and other investors	04/01
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results	08/11
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors	07/11
Polypid Announces the Addition of Dr. Nurit Tweezer-Zaks to Its Board of Directors	07/11
PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023	01/11
PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule	11/10/23
POLYPID : AMENDED AND RESTATED 2012 SHARE OPTION PLAN - Form 6-K	10/10/23
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023	09/10/23
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX and PLEX Technology Platform	05/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas PolyPid Ltd.

Acciones

PYPD

IL0011326795

Otros idiomas

Filtros